Cell density-dependent modulation of basic fibroblast growth factor expression by human interferon-β

International Journal of Oncology

Volumn 8, Issue 4, 1996, Pages 649-656

  Singh, Rakesh K ^a   Bucana, Corazon D ^a   Llansa, Norma ^a   Sanchez, Ricardo ^a   Fidler, Isaiah J ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

bFGF; Cell density; IFN

Indexed keywords

ALPHA INTERFERON; BASIC FIBROBLAST GROWTH FACTOR; BETA INTERFERON; MESSENGER RNA; RECOMBINANT ALPHA2 INTERFERON;

ARTICLE; CELL DENSITY; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; PRIORITY JOURNAL;

EID: 0029927499     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Folkman J: Angiogenesis in cancer, vascular rheumatoid and other diseases. Nature Med 1: 27-31, 1995.
2. Folkman J and Klagsburn M: Angiogenic factors. Science 235: 444-447, 1987.
3. Folkman J: The role of angiogenesis in tumor growth. Semin Cancer Biol 3: 65-71, 1992.
4. Fidler IJ and Ellis LM: The implications of angiogenesis to the biology and therapy of cancer metastasis. Cell 79: 185-188, 1994.
5. Singh RK, Bucana CD, Gutman M, Fan D, Wilson MR and Fidler IJ: Organ site-dependent expression of basic fibroblast growth factor in human renal cell carcinoma cells. Am J Pathol 145: 365-374, 1994.
6. Gutman M, Singh RK, Xie K, Bucana CD and Fidler IJ: Regulation of interleukin-8 expression in human melanoma cells by the organ environment. Cancer Res 55: 2470-2475, 1995.
7. Singh RK, Gutman M, Bucana CD, Sanchez R, Llansa N and Fidler IJ: Interferon-α and -β downregulate the expression of basic fibroblast growth factor in human carcinomas. Proc Natl Acad Sci USA 92: 4562-4566, 1995.
8. Singh RK and Fidler IJ: Regulation of tumor angiogenesis by organ-specific cytokines. In: Attempts to Understand Metastasis Formation. Gunthert U and Birchmeier W (eds). Springer-Verlag, New York (In press).
9. Murphy PR, Sato R, Sato Y and Friesen HG: Fibroblast growth factor messenger ribonucleic acid expression in a human astrocytoma cell line: regulation by serum and cell density. Mol Endocrinol 2: 591-598, 1988.
10. Bost LM and Hjelmeland LM: Cell density regulates differential production of bFGF transcripts. Growth Factors 9: 195-203, 1993.
11. Lin M-F, Garcia-Arenas R, Kawachi M and Lin F-F: Regulation of the expression of prostatic acid phosphatase in LNCaP human prostate carcinoma cells. Cell Mol Biol Res 39: 739-750, 1993.
12. Clement A, Campisi J, Farmer SR and Brody JS: Constitutive expression of growth-related mRNAs in proliferating and nonproliferating lung epithelial cells in primary culture: evidence for growth-dependent translational control. Proc Natl Acad Sci USA 87: 318-322, 1990.
13. Williams JG and Penman S: The messenger RNA sequences in growing and resting mouse fibroblasts. Cell 6: 197-206, 1975.
14. Schneider C, King RM and Philipson L: Genes specifically expressed at growth arrest of mammalian cells. Cell 54: 787-793, 1988.
15. Xie B, Bucana CD and Fidler IJ: Density-dependent induction of 92-kd type IV collagenase activity in culture of A431 human epidermoid carcinoma cells. Am J Pathol 144: 1058-1067, 1994.
16. Muller C, Laval F, Soues S, Birck C and Charcosset J-Y: High cell density-dependent resistance and P-glycoprotein-mediated multidrug resistance in mitoxantrone-selected Chinese hamster cells. Biochem Pharmacol 43: 2091-2102, 1992.
17. Muller C, Laurent G and Ling V: P-glycoprotein stability is affected by serum deprivation and high cell density in multidrug-resistant cells. J Cell Physiol 163: 538-544, 1995.
18. Dean M, Levine RA, Ran W, Kindy MS, Sonenshein GE and Campisi J: Regulation of c-myc transcription and mRNA abundance by serum growth factors and cell contact. J Biol Chem 261: 9161-9166, 1986.
19. Bennett MR, Littlewood TD, Hancock DC, Evan GI and Newby AC: Downregulation of the c-myc protooncogene in inhibition of vascular smooth-muscle cell proliferation: a signal for growth arrest? Biochem J 302: 701-708, 1994.
20. Naito S, Walker S and Fidler IJ: In vivo selection of human renal carcinoma cells with high metastatic potential in nude mice. Clin Exp Metastasis 7: 381-389, 1989.
21. Alley MC, Scudieno DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Schoemaker RH and Boyd MR: Feasibility of drug screening with panels of human tumor cell lines using microculture tetrazolium assay. Cancer Res 48: 589-602, 1988.
22. Fan D, Bucana CD, O'Brian CA, Zwelling LA, Seid C and Fidler IJ: Enhancement of murine tumor cell sensitivity to adriamycin by presentation of drugs in phosphatidylcholine-phosphatidylserine liposomes. Cancer Res 50: 3619-3626, 1990.
23. Radinsky R, Kraemer PM, Raines MA, Kung HJ and Culp LA: Amplification and rearrangement of Kirsten ras oncogene in virus transformed BALB/3T3 cells during malignant tumor progression. Proc Natl Acad Sci USA 84: 5143-5147, 1987.
24. Fort P, Marty L, Liechaczyk M, Sabrouty SE, Dani C and Blanchard JM: Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphadde-hydrogenase multigene family. Nucleic Acids Res 13: 1431-1442, 1985.
25. Rogelj S, Weinberg RA, Fanning P and Klagsbrun M: Basic fibroblast growth factor fused to a signal peptide transforms cells. Nature 331: 173-175, 1988.
26. Feinberg AP and Vogelstein B: A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132: 6-13, 1983.
27. Sunada H, Yu P, Peacock JS and Mendelsohn J: Modulation of tyrosine, serine, and threonine phosphorylation and intracellular processing of the epidermal growth factor receptor by antireceptor monoclonal antibody. J Cell Physiol 142: 284-292, 1990.
28. Gay CG and Winkles JA: Interleukin-1 regulates heparin-binding growth factor 2 gene expression in vascular smooth muscle cells. Proc Natl Acad Sci USA 142: 284-292, 1990.
29. Greenberg ME and Ziff EB: Stimulation of 3T3 cells induces transcription of c-fos protooncogene. Nature 311: 433-438, 1984.
30. Sambrook J, Fritsch EF and Maniatis T: Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratories, Cold Spring Harbor, NY, 1992.
31. Gutterman JU: Cytokine therapeutics: lessons from interferon-α. Proc Natl Acad Sci USA 91: 1198-1205, 1994.
32. Krause D, Panet A, Arad G, Dieffenbach CW and Silverman RH: Independent regulation of PPP (A2′P)NA-dependent RNase in NIH 3T3 clone 1 cells by growth arrest and IFN treatment. J Biol Chem 260: 9501-9507, 1985.
33. Sun L, Wu S, Coleman K, Fields KC, Humphrey LE and Brattain MG: Autocrine transforming growth factor-β1 and -β2 expression is increased by cell crowding and quiescence in colon carcinoma cells. Exp Cell Res 214: 215-224, 1994.
34. Zen K, Masuda J, Sasaguri T, Kosaka C and Ogata J: Gene expression of monocyte chemoattractant protein-1 in human monocytes is regulated by cell density through protein tyrosine kinase and protein kinase C. Exp Cell Res 215: 172-179, 1994.
35. Pocsik E, Mihalik R, Ali-Osman F and Aggarwal BB: Cell-density dependent regulation of cell surface expression of two types of human tumor necrosis factor receptor and its effect on cellular response. J Interferon Res 14: S95 (suppl), 1994.
36. Östman A, Yang Q and Tonks NK: Expression of DEP-1, a receptor-like protein tyrosine phosphatase, is enhanced with increasing cell density. Proc Natl Acad Sci USA 91: 9680-9684, 1994.
37. Stoker MG and Rubin H: Density-dependent inhibition of cell growth in culture. Nature 215: 171-172, 1967.
38. Hunter T: Protein kinases and phosphatases: the ying and yang of protein phosphorylation and signaling. Cell 80: 225-236, 1995.
39. Tonks NK (ed): Introduction: protein tyrosine phosphatases. Semin Cell Biol 4: 373-453, 1993.
40. Fantl WJ, Johnson DE and Williams LT: Signalling by receptor tyrosine kinases. Annu Rev Biochem 62: 453-481, 1993.
41. Tamm I, Lin SL, Pfeiffer LM and Sehgal PB: Interferon-α and -β; as cellular regulatory molecules. Interferon 9: 13-74, 1987.
42. Murphy PR, Sato R, Sato Y and Friesen HG: Regulation of multiple basic fibroblast growth factor messenger ribonucleic acid transcripts by protein kinase C activators. Mol Endocrine 4: 1196-1201, 1988.
43. Sato Y, Murphy PR and Friesen HG: Fibroblast growth factor release by bovine endothelial cells and astrocytome cells in culture is density-dependent. Mol Endocrinol 3: 744-748, 1989.
44. Welch HA, Iberg N, Klagsbrun M and Folkman J: Transcriptional regulation of basic fibroblast growth factor gene expression in capillary endothelial cells. J Cell Biochem 47: 150-164, 1991.
45. Cozzolino F, Torcia M, Lucibello M, Morbidelli L, Ziche M, Platt J, Fabioui S, Brett J and Stern D: Interferon-α and interleukin-2 synergistically enhance basic fibroblast growth factor synthesis and release promoting endothelial cell growth. J Clin Invest 91: 2504-2515, 1993.
46. Shibata F, Baird A and Florkiewicz RZ: Functional characterization of the human basic fibroblast growth factor gene promoter. Growth Factors 4: 277-287, 1991.
47. Dani C, Mechti N, Piechazyk LB, Jeanteur P and Blanchard JM: Increased rate of degradation of c-myc mRNA in interferon-treated Daudi cells. Proc Natl Acad Sci USA 82: 4896-4899, 1985.
48. Dron M, Modjtahedi N, Brison O and Tovey MG: Interferon modulation of c-myc expression in cloned Daudi cells: relationship to the phenotype of interferon resistance. Mol Cell Biol 6: 1374-1378, 1986.
49. Kelly JM, Gilbert CS, Stark GR and Kerr IM: Differential regulation of interferon-induced mRNA and c-myc mRNA by alpha- and gamma-interferons. Eur J Biochem 153: 367-371, 1985.
50. Alexandrow MG and Moses HL: Transforming growth factor-β and cell cycle regulation. Cancer Res 55: 1452-1457, 1995.
51. Ezekowitz RAB, Mulliken JB and Folkman J: Interferon-α2a therapy for life treatening hemangiomas of infancy. N Eng J Med 326: 1456-1463, 1995.